Teva Nominates Former Leumi Chief Galia Maor for Board
Stock Chart for Teva Pharmaceutical Industries Ltd (TEVA)
(Corrects spelling of chairman’s name in third paragraph.)
The company will ask shareholders to approve the nomination at a Sept. 12 meeting, Teva said in a filing. Maor stepped down as CEO of Israel’s largest lender by assets this year after 16 years in the role, in which she was one of the nation’s most prominent female business leaders.
Maor may be a candidate to replace Phillip Frost as chairman of Petach Tikva, Israel-based Teva, Maariv reported on July 25. Maor has the support of directors Amir Elstein and Chaim Hurvitz, the newspaper said, citing people at Teva it didn’t identify.
To contact the editor responsible for this story: Phil Serafino at email@example.com
Bloomberg reserves the right to edit or remove comments but is under no obligation to do so, or to explain individual moderation decisions.